We are live on
!
Find out more
ABMD
Abiomed Inc
ABMD
ABMD
Delisted
ABMD was delisted on the 21st of December, 2022.
8 hedge funds and large institutions have $4.62M invested in Abiomed Inc in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 499 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
98% less funds holding
Funds holding: 517 → 8 (-509)
99% less call options, than puts
Call options by funds: $437K | Put options by funds: $45.7M
100% less capital invested
Capital invested by funds: $10.5B → $4.62M (-$10.5B)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 499
Holders
8
Holders Change
-509
Holders Change %
-98.45%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
6
Closed
499
Calls
$437K
Puts
$45.7M
Net Calls
-$45.2M
Net Calls Change
-$79.7M
Top Buyers
| 1 |
BTI
Blue Trust Inc
Alpharetta,
Georgia
|
+$14K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.29B |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$1.21B |
| 3 |
BlackRock
New York
|
-$1.12B |
| 4 |
State Street
Boston,
Massachusetts
|
-$509M |
| 5 |
Primecap Management
Pasadena,
California
|
-$370M |
